Exchange: NASDAQ·Updated 07:59 PM EDT
LUCD logo

LUCDLucid Diagnostics Inc

$0.9186
$0.0042
(0.46%)
Today
Closed $0.9186
$0.0166
(1.81%)
After Hours
Mkt Cap
$185.68M
52W High
$1.63
52W Low
$0.8956
PE Ratio
-1.96
Avg. Volume
1.68M
EPS (Annual)
-$0.6922
Rev/Employee
$57,390.24
Earnings
Aug 12

About LUCD

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
49

Neutral Sentiment

How do you feel about LUCD?

Advertisement|Remove ads.

Advertisement|Remove ads.